FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060366031> ?p ?o ?g. }

• W2060366031 endingPage "276" @default.
• W2060366031 startingPage "268" @default.
• W2060366031 abstract "The pharmacokinetics of intravenously administered cefepime (1000 mg over 30 minutes) were studied in 5 healthy volunteers and 20 patients with various degrees of renal impairment. Cefepime concentrations in plasma, urine, and hemodialysate were assayed using reverse-phase HPLC with ultraviolet detection. Mean peak plasma concentrations of cefepime at the end of 30-minute infusion ranges from 63.5 to 73.9 μg/ml and were not affected by the degree of renal impairment. The half-life of cefepime was approximately 2.3 hours in subjects with normal kidney function; it increased proportionately as renal function decreased. Significant linear relationships between total body clearance and creatinine clearance, as well as renal clearance and creatinine clearance, were observed. The mean volume of distribution at steady state in healthy volunteers was 20.5 liters and was not significantly altered in subjects with renal insufficiency. The mean cumulative urinary recovery of cefepime in healthy volunteers was 82.9% of the administered dose and significantly decreased in subjects with creatinine clearance less than 30 ml/min. Hemodialysis significantly shortened the elimination half-life from 13.5 hours during the predialysis period to 2.3 hours during the dialysis period. Cefepime dosage should be reduced in proportion to the decline in creatinine clearance. Clinical Pharmacology and Therapeutics (1990) 48, 268–276; doi:10.1038/clpt.1990.149" @default.
• W2060366031 created "2016-06-24" @default.
• W2060366031 creator A5000297567 @default.
• W2060366031 creator A5010343842 @default.
• W2060366031 creator A5020501067 @default.
• W2060366031 creator A5025336433 @default.
• W2060366031 creator A5044813011 @default.
• W2060366031 creator A5064680092 @default.
• W2060366031 date "1990-09-01" @default.
• W2060366031 modified "2023-09-25" @default.
• W2060366031 title "Pharmacokinetics of cefepime in subjects with renal insufficiency" @default.
• W2060366031 cites W1831388519 @default.
• W2060366031 cites W1967406444 @default.
• W2060366031 cites W1972214008 @default.
• W2060366031 cites W1998817239 @default.
• W2060366031 cites W2016815689 @default.
• W2060366031 cites W2018861391 @default.
• W2060366031 cites W2036520108 @default.
• W2060366031 cites W2078251568 @default.
• W2060366031 cites W2089043015 @default.
• W2060366031 cites W2092566765 @default.
• W2060366031 cites W2104893459 @default.
• W2060366031 cites W2411347878 @default.
• W2060366031 cites W2918050307 @default.
• W2060366031 doi "https://doi.org/10.1038/clpt.1990.149" @default.
• W2060366031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2401125" @default.
• W2060366031 hasPublicationYear "1990" @default.
• W2060366031 type Work @default.
• W2060366031 sameAs 2060366031 @default.
• W2060366031 citedByCount "113" @default.
• W2060366031 countsByYear W20603660312012 @default.
• W2060366031 countsByYear W20603660312013 @default.
• W2060366031 countsByYear W20603660312014 @default.
• W2060366031 countsByYear W20603660312015 @default.
• W2060366031 countsByYear W20603660312016 @default.
• W2060366031 countsByYear W20603660312017 @default.
• W2060366031 countsByYear W20603660312018 @default.
• W2060366031 countsByYear W20603660312019 @default.
• W2060366031 countsByYear W20603660312020 @default.
• W2060366031 countsByYear W20603660312021 @default.
• W2060366031 countsByYear W20603660312022 @default.
• W2060366031 countsByYear W20603660312023 @default.
• W2060366031 crossrefType "journal-article" @default.
• W2060366031 hasAuthorship W2060366031A5000297567 @default.
• W2060366031 hasAuthorship W2060366031A5010343842 @default.
• W2060366031 hasAuthorship W2060366031A5020501067 @default.
• W2060366031 hasAuthorship W2060366031A5025336433 @default.
• W2060366031 hasAuthorship W2060366031A5044813011 @default.
• W2060366031 hasAuthorship W2060366031A5064680092 @default.
• W2060366031 hasConcept C112705442 @default.
• W2060366031 hasConcept C126322002 @default.
• W2060366031 hasConcept C126894567 @default.
• W2060366031 hasConcept C139254425 @default.
• W2060366031 hasConcept C159641895 @default.
• W2060366031 hasConcept C185592680 @default.
• W2060366031 hasConcept C2776768635 @default.
• W2060366031 hasConcept C2777050379 @default.
• W2060366031 hasConcept C2778063415 @default.
• W2060366031 hasConcept C2779631663 @default.
• W2060366031 hasConcept C2779978075 @default.
• W2060366031 hasConcept C2780026642 @default.
• W2060366031 hasConcept C2780306776 @default.
• W2060366031 hasConcept C3941253 @default.
• W2060366031 hasConcept C501593827 @default.
• W2060366031 hasConcept C55493867 @default.
• W2060366031 hasConcept C6557445 @default.
• W2060366031 hasConcept C71924100 @default.
• W2060366031 hasConcept C86803240 @default.
• W2060366031 hasConcept C94665300 @default.
• W2060366031 hasConcept C98274493 @default.
• W2060366031 hasConceptScore W2060366031C112705442 @default.
• W2060366031 hasConceptScore W2060366031C126322002 @default.
• W2060366031 hasConceptScore W2060366031C126894567 @default.
• W2060366031 hasConceptScore W2060366031C139254425 @default.
• W2060366031 hasConceptScore W2060366031C159641895 @default.
• W2060366031 hasConceptScore W2060366031C185592680 @default.
• W2060366031 hasConceptScore W2060366031C2776768635 @default.
• W2060366031 hasConceptScore W2060366031C2777050379 @default.
• W2060366031 hasConceptScore W2060366031C2778063415 @default.
• W2060366031 hasConceptScore W2060366031C2779631663 @default.
• W2060366031 hasConceptScore W2060366031C2779978075 @default.
• W2060366031 hasConceptScore W2060366031C2780026642 @default.
• W2060366031 hasConceptScore W2060366031C2780306776 @default.
• W2060366031 hasConceptScore W2060366031C3941253 @default.
• W2060366031 hasConceptScore W2060366031C501593827 @default.
• W2060366031 hasConceptScore W2060366031C55493867 @default.
• W2060366031 hasConceptScore W2060366031C6557445 @default.
• W2060366031 hasConceptScore W2060366031C71924100 @default.
• W2060366031 hasConceptScore W2060366031C86803240 @default.
• W2060366031 hasConceptScore W2060366031C94665300 @default.
• W2060366031 hasConceptScore W2060366031C98274493 @default.
• W2060366031 hasIssue "3" @default.
• W2060366031 hasLocation W20603660311 @default.
• W2060366031 hasLocation W20603660312 @default.
• W2060366031 hasOpenAccess W2060366031 @default.
• W2060366031 hasPrimaryLocation W20603660311 @default.
• W2060366031 hasRelatedWork W1971388241 @default.
• W2060366031 hasRelatedWork W2034941908 @default.

• next